251 related articles for article (PubMed ID: 4996463)
1. [Comparative evaluation of thiphosphamide, cyclophosphane, methotrexate and 5-fluorouracil in the treatment of breast cancer].
Sokolova VD; Perevodchikova NI
Vestn Akad Med Nauk SSSR; 1971; 26(3):59-65. PubMed ID: 4996463
[No Abstract] [Full Text] [Related]
2. Combination chemotherapy for advanced mammary carcinoma: a twelve-year experience.
Greenspan EM
Mt Sinai J Med; 1972; 39(5):435-46. PubMed ID: 4628078
[No Abstract] [Full Text] [Related]
3. [FSH and steroid hormone excretion in breast cancer during chemotherapy].
Sokolova VD; Sharoukhova KS; Goncharova MG; Murav'eva NI; Smirnova KD
Vopr Onkol; 1972; 18(10):19-22. PubMed ID: 4197020
[No Abstract] [Full Text] [Related]
4. [Features of regressive changes during chemotherapy of breast cancer metastases to the lungs].
Dymarskiĭ LIu; Chernomordikova MF
Klin Med (Mosk); 1972 Jun; 50(6):35-42. PubMed ID: 4628708
[No Abstract] [Full Text] [Related]
5. [Antineoplastic polychemotherapy in thoracic pathology].
Mannes P; Derriks R; Moens R; Heynen E
Poumon Coeur; 1968; 24(1):83-91. PubMed ID: 4968018
[No Abstract] [Full Text] [Related]
6. Treatment of hepatic metastases from breast cancer.
Bugarski M; Vuletić L; Boberić J; Milosavljević A; Dilparić S; Tomin R; Naumović P
Clin Oncol; 1978 Jun; 4(2):167-71. PubMed ID: 668248
[No Abstract] [Full Text] [Related]
7. [Endolymphatic polychemotherapy of cancer of the ovaries].
Pankov AK; Sidorenko IuS; Il'inskaia EG; Birbraer VM
Vopr Onkol; 1975; 21(4):55-7. PubMed ID: 812260
[No Abstract] [Full Text] [Related]
8. Cyclic combination chemotherapy for metastatic breast cancer.
Biran S; Krasnokuki D; Hochman A; Brufman G
Isr J Med Sci; 1977 Jun; 13(6):582-6. PubMed ID: 885710
[TBL] [Abstract][Full Text] [Related]
9. Combination chemotherapy for disseminated carcinoma of the breast.
Lozada JA; Grillo-López A; Vélez-Garciá E
Bol Asoc Med P R; 1975 Jun; 67(6):157-63. PubMed ID: 1055588
[No Abstract] [Full Text] [Related]
10. An evaluation of five drug combination chemotherapy in the management of recurrent carcinoma of the breast.
Lee JM; Abeloff MD; Lenhard RE; Baker RR
Surg Gynecol Obstet; 1974 Jan; 138(1):77-80. PubMed ID: 4809006
[No Abstract] [Full Text] [Related]
11. [Treatment of metastases of breast cancer by an immediate combination of hormonal treatment and chemotherapy with nonhormonal cytostatics].
Mannes P; Derriks R
Acta Tuberc Pneumol Belg; 1968; 59(2):445-54. PubMed ID: 5720490
[No Abstract] [Full Text] [Related]
12. Thio-tepa and endoxan in combined treatment of breast cancer (cooperative trial).
Blokhina NG; Karev NI
Radiobiol Radiother (Berl); 1974; 15(3):357-60. PubMed ID: 4217461
[No Abstract] [Full Text] [Related]
13. A pilot study of sequential combination chemotherapy with adriamycin and cyclophosphamide, and methotrexate, 5-fluorouracil and prednisolone in advanced breast cancer.
Collis CH
Br J Clin Pract; 1978 May; 32(5):139-44. PubMed ID: 666968
[No Abstract] [Full Text] [Related]
14. Cyclical combination chemotherapy in advanced breast cancer.
Edelstyn GA; Marcrae KD
Ann R Coll Surg Engl; 1974 Jun; 54(6):275-6. PubMed ID: 4833779
[No Abstract] [Full Text] [Related]
15. [CMF (cyclophosphamide, methotrexate, ftorafur) chemotherapy in advanced breast cancer].
Gottwald G; Szakolczai I
Orv Hetil; 1983 Jan; 124(2):79-84. PubMed ID: 6687491
[No Abstract] [Full Text] [Related]
16. Cyclophosphamide. Evaluation in recurrent and progressive ovarian cancer.
Decker DG; Malkasian GD; Mussey E; Johnson CE
Am J Obstet Gynecol; 1967 Mar; 97(5):656-65. PubMed ID: 4959953
[No Abstract] [Full Text] [Related]
17. CMF versus CMF plus tamoxifen in advanced breast cancer in postmenopausal women. An EORTC trial.
Mouridsen HT; Palshof T; Engelsman E; Sylvester R
Eur J Cancer (1965); 1980; Suppl 1():119-23. PubMed ID: 7032921
[No Abstract] [Full Text] [Related]
18. [Role and limitations of chemotherapy in breast cancer].
Cattan A; Pourny C
Sem Hop; 1975 Jul 10-20; 51(31-34):2119-21. PubMed ID: 170687
[No Abstract] [Full Text] [Related]
19. Adjuvant chemotherapy with cyclophosphamide, methotrexate, and 5-fluorouracil, vincristine, and prednisone compared with single-agent L-phenylalanine mustard for patients with operable breast carcinoma and positive axillary lymph nodes: 20-year results of a Southwest Oncology Group study.
Rivkin SE; Green SJ; Lew D; Costanzi JJ; Athens JW; Osborne CK; Vaughn CB; Martino S
Cancer; 2003 Jan; 97(1):21-9. PubMed ID: 12491501
[TBL] [Abstract][Full Text] [Related]
20. [A case of successful use of 5-fluorouracil and cyclophosphane in metastasis of cancer of the breast].
Dymarskiĭ LIu; Chernomordikova MF
Klin Med (Mosk); 1968 Sep; 46(9):124-6. PubMed ID: 5715264
[No Abstract] [Full Text] [Related]
[Next] [New Search]
